Publications by authors named "Lise Holterbach"
On 6 July 2018, the Center for Epidemiology and Public Health of the French Armed Forces was informed of an outbreak of acute gastroenteritis among customers of a dining facility at a military base in Brittany, France. A total of 200 patients were reported out of a population of 1700 (attack rate: 12%). The symptoms were mainly lower digestive tract disorders and occurred rapidly after lunch on 5 July (median incubation period: 3.
View Article and Find Full Text PDFIntroduction: Meloidae are distributed in temperate and arid regions but are also common in subtropical and tropical savannahs. These insects contain cantharidin, a vesicant substance that can cause poisoning by ingestion and dermatitis by direct contact.
Material And Methods: We describe recurrent Meloidae-related dermatitis outbreaks and their health impact by analyzing medical consultation records and meteorological data.
Objectives: No immunomodulatory drug has been approved for primary Sjögren's syndrome, a systemic autoimmune disease affecting 0.1% of the population. To demonstrate the efficacy of targeting interleukin 6 receptor in patients with Sjögren's syndrome-related systemic complications.
View Article and Find Full Text PDFArticle Synopsis
- The study investigated the impact of lanreotide on high-output stomas (HOS), which can cause serious complications like dehydration and renal failure in about 3-16% of patients.
- The research involved a randomized trial comparing patients receiving lanreotide combined with antidiarrhoeal treatments against those receiving antidiarrhoeal treatments only, focusing on ileostomy output after 72 days.
- Results showed no significant differences in stoma output, renal function, or hospital stay lengths, leading to an early termination of the trial due to low patient enrollment and ongoing uncertainty about the effectiveness and cost of somatostatin analogues in treating HOS.*